No Data
Jingye Asia Vets (688290): Profit improvement in the third quarter of 2024, Nuclear Industry & Global Strategy synchronously exerting efforts.
The performance in the third quarter of 2024 meets our expectations. The company released the performance for 2024Q3: revenue of 0.149 billion yuan (+15.7% year-on-year), net income attributable to shareholders of 7.06 million yuan (+255% year-on-year), in line with our expectations.
Jingye Intelligence: Jingye Intelligence Report for the Third Quarter of 2024
Jingye Intelligence Report for the Third Quarter of 2024
Asia Vets (688290.SH) released the performance for the first three quarters, with a net income of 7.06 million yuan, a year-on-year increase of 255.38%.
Jingye Asia Vets (688290.SH) disclosed the third quarter report for 2024, during the reporting period, the company achieved a revenue of 1.4...
Jingye Asia Vets (688290.SH) plans to distribute 0.5 yuan per 10 shares at the mid-year of 2024.
Jingye Asia Vets (688290.SH) announced that the company's 2024 interim dividend plan: intends to distribute to all shareholders each...
Jingye asia vets (688290.SH): The mid-term dividend is proposed to be 0.5 yuan per 10 shares.
On October 23, Jinye Asia Vets (688290.SH) announced that the company's 2024 interim dividend plan is as follows: The company plans to distribute a cash dividend of 0.5 yuan (including tax) per 10 shares to all shareholders. As of now, the total share capital of the company (excluding shares held in the repurchase special securities account) is 101.356006 million shares, based on this calculation, the total proposed cash dividend is 5.0678 million yuan (including tax), accounting for 71.77% of the net income attributable to the shareholders of the listed company in the third quarter of 2024.
No Data
No Data